Core Laboratories N.V.

NYSE: CLB · Real-Time Price · USD
10.95
-0.14 (-1.26%)
At close: Jun 05, 2025, 3:59 PM
10.97
0.18%
After-hours: Jun 05, 2025, 04:04 PM EDT

Core Laboratories Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023
Product Revenue 135.64M 137.88M
Product Revenue Growth -1.62% n/a
Service Revenue 388.2M 371.91M
Service Revenue Growth +4.38% n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Other Countries Revenue 344.95M 331.24M 323.03M 322.07M 328.33M 353.8M 342.14M 342.53M 347.33M 414.81M 464.33M 445.57M 374.49M 351.76M
Other Countries Revenue Growth +4.14% +2.54% +0.30% -1.91% -7.20% +3.41% -0.11% -1.38% -16.27% -10.67% +4.21% +18.98% +6.46% n/a
United States Revenue 178.9M 178.55M 166.7M 148.18M 158.94M 289.17M 324.07M 284.26M 224.86M 338.91M 515.64M n/a n/a n/a
United States Revenue Growth +0.19% +7.11% +12.50% -6.77% -45.04% -10.77% +14.01% +26.41% -33.65% -34.27% n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 13.65M 9.08M 8.33M 10.26M 11.79M 8.66M 9.45M 5.81M 16.33M 8.72M 10M 6.85M 12.54M 10.93M 15.12M 9.67M 8.46M -3.69M 8.94M 9.22M 19.57M 9.77M 11.01M 9.8M 17.44M 24.72M 13.28M 12.2M 12.71M 11.99M 11.89M 11.1M 12.76M 8.79M 8.41M 11.14M 11.05M 12.27M 12.15M 12.63M 12.67M
Selling, General, and Administrative Revenue Growth +50.30% +9.03% -18.82% -12.98% +36.05% -8.33% +62.66% -64.42% +87.20% -12.77% +46.06% -45.42% +14.81% -27.71% +56.31% +14.29% -329.17% -141.31% -3.08% -52.87% +100.21% -11.25% +12.36% -43.79% -29.46% +86.18% +8.82% -3.99% +5.96% +0.90% +7.09% -12.98% +45.04% +4.63% -24.54% +0.81% -9.91% +0.91% -3.79% -0.32% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a